Vor Biopharma Inc. Announces $55.6 Million Private Placement

Vor Biopharma Inc. recently disclosed in an 8-K filing with the Securities and Exchange Commission (SEC) that on December 26, 2024, the company entered into a Securities Purchase Agreement with certain investors. Under this agreement, Vor Biopharma agreed to issue and sell an aggregate of 55,871,260 shares of its common stock, along with accompanying warrants, […]

Leave a Reply

Your email address will not be published.

Previous post Tribe Capital Growth Corp I Extends Business Combination Agreement and PIPE Equity Subscription Agreement
Next post Amedisys (NASDAQ: AMED) and UnitedHealth Group Incorporated have recently announced a crucial waiver in their ongoing merger proceedings. The waiver, finalized on December 26, 2024, is designed to address potential hurdles in the merger process betwe